RXEarnings•globenewswire•
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
Sentiment:Negative (0)
Summary
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June 30, 2025 on Thursday, August 21, 2025 after market hours. A presentation on the Company’s second quarter and first half 2025 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by globenewswire